NeuroEM
Built upon a decade of groundbreaking research, NeuroEM is reversing cognitive decline from Alzheimer’s, aging, and neurodegenerative diseases with safe, effective, non-invasive, and drug-free innovation.
02/02/2026
ICYMI: Dr. W. Scott Burgin has joined NeuroEM as Chief Medical Officer, bringing what CEO Chuck Papageorgiou calls a "rare combination of clinical excellence, scientific rigor, and entrepreneurial vision [that] aligns perfectly with our mission to advance transformative neurological care." https://ow.ly/OCxt50Y6G9t
01/31/2026
In a move that marks an exciting and important milestone for NeuroEM, the company announced today the appointment of Dr. W. Scott Burgin as Chief Medical Officer. His decades of leadership in stroke neurology, deep expertise in AI‑driven innovation, and track record of translating research into real‑world impact represent the forward‑thinking perspective that will accelerate NeuroEM's next growth phase.
https://ow.ly/Rqfn50Y6G8X
01/13/2026
CEO Chuck Papageorgiou will be among the Health Transformers in the StartUp Health Apollo House today. He represents the 's & Brain Health Moonshot on behalf of NeuroEM, a member of the StartUp Health Alzheimer’s Moonshot Community, and will advance the mission of empowering cognitive health by reversing cognitive decline and promoting lasting wellness through innovations for a brighter future.
Apollo House is an exclusive networking summit during J.P. Morgan Healthcare Week that brings together 500 top founders, funders, and industry leaders to advance Health Moonshots in the Age of . -RF https://ow.ly/tmgP50XWf2U
11/27/2025
Happy Thanksgiving!
11/11/2025
From everyone at NeuroEM, thank you to all who serve.
Click here to claim your Sponsored Listing.